VIRGINIA COMMONWEALTH UNIVERSITY
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vcu.edu
Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)
Phase 2
Completed
- Conditions
- Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome
- Interventions
- Other: Placebo
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 132
- Registration Number
- NCT02878798
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States
๐บ๐ธVirginia Commonwealth University, Richmond, Virginia, United States
๐บ๐ธUniversity of Miami, Miami, Florida, United States
Centering Pregnancy Care + Yoga for Diverse Pregnant Women
Not Applicable
Completed
- Conditions
- Pregnancy
- Interventions
- Behavioral: Centering Pregnancy Care plus Yoga (CPC+Y)
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 40
- Registration Number
- NCT02873481
- Locations
- ๐บ๐ธ
Virginia Commonwealth University School of Nursing, Richmond, Virginia, United States
Addressing Modifiable Breast Cancer Risk Factors With Project CONECT
Not Applicable
Completed
- Conditions
- Weight LossBreast Cancer Risk Factors
- Interventions
- Behavioral: CONECT
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 14
- Registration Number
- NCT02871388
- Locations
- ๐บ๐ธ
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States
SGLT2 Inhibition in Diabetes and Heart Failure
Completed
- Conditions
- Heart Failure, SystolicDiabetes Mellitus, Type 2
- First Posted Date
- 2016-08-10
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 18
- Registration Number
- NCT02862067
- Locations
- ๐บ๐ธ
Virginia Commonwealth University, Richmond, Virginia, United States
RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease
Phase 1
Completed
- Conditions
- ConstipationGastroparesisParkinson's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 51
- Registration Number
- NCT02838797
- Locations
- ๐บ๐ธ
VCU NOW Center, Henrico, Virginia, United States
TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Phase 1
Completed
- Conditions
- Mycosis FungoidesSรฉzary Syndrome
- Interventions
- Radiation: TSEB Therapy
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2019-08-30
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 5
- Registration Number
- NCT02822586
- Locations
- ๐บ๐ธ
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
Phase 1
Terminated
- Conditions
- Renal Cell CarcinomaMetastatic DiseaseSoft Tissue Sarcoma
- Interventions
- First Posted Date
- 2016-06-10
- Last Posted Date
- 2019-10-24
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 6
- Registration Number
- NCT02795819
- Locations
- ๐บ๐ธ
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States
Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System
Phase 1
Terminated
- Conditions
- Obstetric AnesthesiaCesarean Section
- Interventions
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2018-04-24
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 14
- Registration Number
- NCT02787928
- Locations
- ๐บ๐ธ
Virginia Commonwealth University, Richmond, Virginia, United States
Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer's
Not Applicable
Terminated
- Conditions
- Alzheimer's Disease
- Interventions
- Radiation: 10 GY in 5 daily fractionsRadiation: 20 GY in 10 daily fractions
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2021-12-16
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 5
- Registration Number
- NCT02769000
- Locations
- ๐บ๐ธ
Virginia Commonwealth University, Richmond, Virginia, United States
High Dose Vitamin C in Cardiac Surgery Patients
Phase 1
Terminated
- Conditions
- Disorder of Vitamin CComplications Due to Coronary Artery Bypass GraftAtrial FibrillationHeart Valve Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-05-04
- Last Posted Date
- 2019-06-24
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 6
- Registration Number
- NCT02762331
- Locations
- ๐บ๐ธ
Virginia Commonwealth University Health System, Richmond, Virginia, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath